In summary, the genetic heterogeneity of Chinese CBAVD patients differs from the hotspot mutation pattern of Caucasians.We recommend targeted gene testing for the CFTR and ADGRG2 genes in CBAVD patients. The gene discussed is ADGRG2; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.